AVROBIO Inc at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript
Hi, everyone. My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. It's with great pleasure that I'd like to welcome Geoff MacKay, the CEO of AVROBIO. Thanks for joining us today, Geoff. I'll turn it over to you to tell everyone more about the Company. (Conference Instructions)
Great. Thank you very much, Maury. Real pleasure to have the opportunity to present our Company to you. Before we begin, just highlight that the presentation will contain forward-looking statements based on our current expectations and beliefs, and I refer you to our SEC filings for further information.
The founding purpose of AVROBIO remains freedom from a lifetime of disease. And what that means to us and to our indications is ideally delivery of radically better outcomes for devastating diseases, number one, but number two, to untether patients from weekly or biweekly infusions, in other words to enable patients, people to reach their full
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |